Diagnostic Approach for Granulosa Cell Tumors of the Ovaries
The diagnosis of ovarian granulosa cell tumors requires a comprehensive workup including pelvic ultrasound, abdomino-pelvic CT scan, chest X-ray, and PET scan in selected cases, along with specific tumor markers and histopathological confirmation by an expert pathologist. 1
Clinical Presentation
Granulosa cell tumors (GCTs) typically present with:
- Subacute pelvic pain
- Feeling of pelvic pressure due to pelvic mass
- Menstrual irregularities 1
- Postmenopausal bleeding (in older women) due to endometrial hyperplasia 1
- Hormonal manifestations (estrogen excess) 1
- Some patients (approximately 30%) may be asymptomatic 2
Diagnostic Algorithm
Step 1: Imaging Studies
Transvaginal and transabdominal ultrasound (first-line imaging)
Abdomino-pelvic CT scan - for better characterization and staging 1
Chest X-ray - to rule out metastatic disease 1
PET scan - in selected cases for evaluation of metastatic disease 1
Step 2: Laboratory Tests
- Hormone levels:
- Other tumor markers:
- CA-125 (may be elevated but non-specific)
- Complete blood count
- Liver and renal function tests 1
Step 3: Endometrial Assessment
- Endometrial curettage/biopsy - must be performed to rule out concomitant uterine cancers, as endometrial pathology is found in up to 54% of patients due to estrogen production by the tumor 1, 2
Step 4: Histopathological Confirmation
- Surgical specimen - definitive diagnosis requires histopathological examination 1
- Expert pathologist review - histological second opinion by an expert pathologist should always be considered 1
Histopathological Diagnosis
Adult form characteristics:
- Small uniform cells with scanty cytoplasm
- Grooved nuclei ("coffee bean" appearance)
- Small eccentric nucleoli
- Macrofollicular, microfollicular, solid, insular or trabecular patterns
- Characteristic Call-Exner bodies 1
Immunohistochemistry panel:
- Inhibin alpha (positive)
- Calretinin (positive)
- FOXL2 (positive)
- CD99 and melan A (positive) 1
Molecular testing:
- FOXL2 (402C-G) mutation analysis - useful to confirm diagnosis in morphologically ambiguous cases 1
Diagnostic Challenges and Pitfalls
- GCTs can be misdiagnosed as benign or other cystic tumors, especially when presenting as pure cystic lesions 5
- Juvenile GCTs (occurring in patients <20 years) may present differently with sexual precocity 1
- Varying histopathological features can make diagnosis difficult, including tumor cells with luteinization or free cell clusters 5
- Differential diagnosis includes other ovarian tumors, particularly endometrioid carcinoma or carcinoid tumors 1
Follow-up After Diagnosis
- Regular follow-up with transvaginal ultrasound is essential for monitoring recurrence 3
- Inhibin levels should be monitored to detect recurrence 6
- Sonographic features of recurrences are comparable to those of primary tumors 3
Key Points to Remember
- GCTs account for 2-8% of all ovarian malignancies 7
- They are more difficult to diagnose than epithelial ovarian tumors 7
- Most GCTs are unilateral and confined to the ovary at diagnosis 1
- Bilateral presentation is rare, especially with pure cystic features 5
- Tumor stage at diagnosis remains the most important prognostic factor 1
By following this diagnostic approach, clinicians can accurately identify granulosa cell tumors of the ovary and initiate appropriate treatment to improve patient outcomes.